Rebalix
Logo SPDRSPDR · sheet of 10 September 2026
ETF sheet · official issuer and register data

State Street® SPDR® MSCI Europe Value UCITS ETF

ZPRW · IE00BSPLC306 · EUR · domicile Ireland
Equity · Europe · ValueSFDR art. 6 (inferred)
Index tracked: MSCI Europe Value Exposure Select Index
TER
0.20%+ trans. 0.03%
Fund size
83 m EUR
Tracking difference
+0.27%3-year avg
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Physical (full replication)
Income
Accumulating
Launch 17 Feb 2015 · costs from the KID as of 2 Sept 2026 · 122 securities held · 8 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 5 Aug 2026
Investment objective The investment objective of the Fund is to track the performance of European equities with a higher weighting applied to equities exhibiting low valuation characteristics. The Fund seeks to track the performance of the MSCI Europe Value Exposure Select Index (the "Index") as closely as possible. The Fund is an index tracking fund (also known as a passively managed fund). Investment policies The Fund invests primarily in securities included in the Index. These securities include large and mid-sized European companies that exhibit…

Performance since series start (in euro) — base 100

18 Feb 20158 Sept 2026 · dividends reinvested where declared by the issuer
20162018202020222024202626374259
High 263 (5 Aug 2026) · low 74 (19 Mar 2020) · last 259. Past performance is not indicative of future results.

Returns in euro

1 year+32.7%
3 years+82.3%
5 years+97.8%
10 years+182.0%
Since series start+159.4%

Risk · 1 / 3 / 5 years

Volatility (ann.)12.58%12.78%14.23%
Max drawdown−9.16%−16.94%−18.37%
Sharpe2.071.340.86
Sortino3.251.891.19
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · ZPRW · IE00BSPLC3061
RebalixZPRW · IE00BSPLC306 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · declared by the issuer
YearFundIndexTD
2025+34.58%+34.42%+0.16%
2024+9.36%+9.09%+0.27%
2023+14.28%+13.89%+0.39%
2022−4.82%−5.04%+0.22%
2021+28.14%+28.17%−0.03%

Holdings

Portfolio as declared by the issuer · 31 Aug 2026 · 122 securities · top-10 weight = 31.5%
Top holdingsWeight
BNP Paribas S.A. Class A4.7%
British American Tobacco p.l.c.3.6%
Banco Bilbao Vizcaya Argentaria S.A.3.6%
Capgemini SE3.4%
Roche Holding Ltd3.3%
Novartis AG2.7%
Barclays PLC2.7%
DHL AG2.6%
Deutsche Bank Aktiengesellschaft2.5%
Rio Tinto plc2.4%
Countries (% of fund)
France26.8%United Kingdom23.4%Germany15.9%Switzerland8.0%Sweden6.9%
Sectors (% of fund)
Financials26.9%Industrials19.1%Health Care13.2%Information Technology8.1%Consumer Staples7.6%

Listing venues

ESMA register (FIRDS) and official exchange lists
ZPRW · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 18 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.ssga.com/library-content/kids?isin=IE00BSPLC306&documentType=kid&c
Factsheet · www.ssga.com/library-content/products/factsheets/etfs/emea/factsheet-e
Prospectus · www.ssga.com/library-content/products/fund-docs/etfs/emea/1-IE-EN-FP-I
The live sheet, always up to date
rebalix.com/en/etf/IE00BSPLC306
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · ZPRW · IE00BSPLC3062